Latest Articles
From period pain to heart disease, the gender health gap is real — here’s how to close it - Down To Earth
From period pain to heart disease, the gender health gap is real — here’s how to close it Down To Earth
Published: June 3, 2025, 6:12 a.m.
Aussie tradie dies in horror workplace accident while operating cherry picker near powerlines - Daily Mail
Aussie tradie dies in horror workplace accident while operating cherry picker near powerlines Daily Mail
Published: June 3, 2025, 1:30 a.m.
How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic - MedCity News
How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic MedCity News
Published: June 3, 2025, 1:19 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
ETH Zurich Unveils ‘MenstruAI’: Groundbreaking Device Uses Menstrual Blood to Monitor Women’s Health - 247news.com.pk
ETH Zurich Unveils ‘MenstruAI’: Groundbreaking Device Uses Menstrual Blood to Monitor Women’s Health 247news.com.pk
Published: June 2, 2025, 2:53 p.m.
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting - Cobb Courier
When doctors don’t believe their patients’ pain – experts explain the all-too-common experience of medical gaslighting Cobb Courier
Published: June 2, 2025, 10:07 a.m.
This Condition May Raise Your Risk of Autoimmune Disease - AOL.com
This Condition May Raise Your Risk of Autoimmune Disease AOL.com
Published: June 2, 2025, 8:57 a.m.
Link copied to clipboard!